Document is current
Any future updates will be listed below
-
Authors
Winter, Judith C.
Thieme, Katharina https://orcid.org/0000-0002-4585-6916
Eule, J. Corinna
Saliu, Eva-Maria
Kershaw, Olivia
Gehlen, Heidrun
-
Funding
Funding for this research was provided by:
Freie Universität Berlin
- License Information
-
More Information
Article History
Received: 19 October 2021
Accepted: 26 January 2022
First Online: 26 February 2022
Declarations
:
: There were no associated ethical issues in this clinical study and all the owners gave their consent for all tests and procedures.
: All horse owners gave their consent, that their horses´ data and photographs could be used for scientific purposes.
: The authors declare no conflict of interest.
: <sup>a</sup>VetScan HM 5, Scil animal care company GmbH, Viernheim, Germany<sup>b</sup>Laboklin GmbH & Co. KG, Bad Kissingen, Germany; certified according to DIN EN ISO/IEC 17025:2005<sup>c</sup>Reflotron® plus Roche Deutschland Holding GmbH, Grenzach-Wyhlen/Germany<sup>1</sup>Equisolon, Böhringer Ingelheim Vetmedica GmbH, Ingelheim, Germany<sup>2</sup>Gent-Ophtal®, Ursapharm Arzneimittel GmbH, Saarbrücken, Germany<sup>3</sup>ProntoVet®, B.Braun Melsungen AG, Melsungen, Germany<sup>4</sup>Navalis Orthosal® Selen, Navalis® nutraceuticals GmbH, Filderstadt<sup>5</sup>Azathioprin HEXAL® 100 mg, Hexal AG, Holzkirchen, Germany<sup>6</sup>Flunidol® 5%, cp-pharma Handelsgesellschaft mbH, Burgdorf, Germany<sup>7</sup>Equizol®, cp-pharma Handelsgesellschaft mbH, Burgdorf, Germany<sup>8</sup>Vitamycin® Augensalbe, cp-pharma Handelsgesellschaft mbH, Burgdorf, Germany<sup>9</sup>Atropin-POS 0,5 %, Ursapharm Arzneimittel GmbH, Saarbrücken, Germany<sup>10</sup>Dexa-Gentamicin, Ursapharm Arzneimittel GmbH, Saarbrücken, Germany<sup>11</sup>Omni-Sorb®, Omnivision GmbH, Wien, Austria<sup>12</sup>Panthenol-ratiopharm® Wundbalsam, ratiopharm GmbH, Ulm, Germany
